I haven’t sold a share. I won’t sell a share. There is

New Post Public Reply Private Reply Replies (0) Message Board
Goosebumps
501
I haven’t sold a share. I won’t sell a share. There is no need to sell a share. The share price will come back. Some will lose and some who stay will win in the end. Why... because some will believe in the science. That’s the bottom line. We all have ran the numbers here on the board and we know that the overall percentages and they show a home run. You know it... I know it... and now the FDA and other agencies know it.

Hence the reason to negotiate. What would we negotiate? There are a few things we should negotiate. If I am Cytodyn I would negotiate after seeing what kind of help the FDA is offering. Fast tracked production facilities other than what we have already? Help with down payments on manufacturing? Help with a great PR so the Doctors in our country and the world know what all should know. For these items to help progress our manufacturing. We negotiate in good faith what the FDA seeks in volume and price commitments.

Does anyone see it any different? What else is there to negotiate. EUA is a given what we already know and the FDA also knows this. Otherwise we wouldn’t be in negotiations at all. So we either negotiate a deal with the FDA or we move on to other markets and the FDA knows this since we let out a PR today to inform them yet again that they are not the only game in town and we will sell our inventory to whomever negotiates the best deal or offers the most help. Fact is we will probably have the Philippines buying their 100,000 promised doses first before any other deals and that will fund some manufacturing. The Philippines just wanted the mortality and that only took minutes to do that math. If I am Nader I am leaning back in the biggest chair in the room and chewing on a cigar flicking a lighter with the threat of lighting it at any moment but not lighting it because he knows deep down he is holding the best hand possible and his cell phone won’t stop ringing and he keeps the attention of the FDA by saying “ damn... that is the MHRA again” then the next ring damn that’s Health Canada yet again. Then smugly asking ... so what are you thinking? How can you help us?

So when you look at the big picture in a negotiation way. The FDA doesn’t hold the best hand and they know it. Hence asking for confidential negotiations to keep Janet Woodcock in the running for full time FDA commissioner. As for confidential negotiations... you know this isn’t something that Nader would of suggested. He would be crowing from the tallest building in Vancouver Washington. Telling the world what we have.

This is my opinion on how the day has progressed. I hope it’s somewhere close to what I have said. I may be way off but one thing I do know is the science supports what we all know. That the efficacy of the trial is probably even better that what everyone thought except me. Ask your self why is there secrecy at all if the FDA isn’t worried they can’t strike a deal? Every vaccine company has announced preliminary results in the past. Even before making a deal. Every other therapeutic has fallen with no results in Severe to Critical and announced even before all data was announced and most even after getting to a mid trial analysis.

What we know is we are ready and everyone wants a piece of our pie... there will be no cake served here...

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Hims & Hers Health Hit by FTC Claims and Class Action

Updated Category News Views 8

Hims Faces Harsh Lessons With FTC Lawsuit There's trouble brewing in the world of telehealth, and Hims & Hers Health (NYSE: HIMS) is right at the eye of the storm. They've gone from a darling of digital health to a pariah faster than you can say 'data breach.' On July 29, 2026, they took a hit so hard you’d think the company stepped into the ring with a heavyweight...

Continue Reading
Verdafero Gains Ground in Sustainable Hospitality

Updated Category News Views 1

Verdafero's Latest Milestone: A Broader Environmental Reach It’s a day like today that makes you pause and realize that businesses in the hospitality space aren’t just about fluff and fancy lobbies anymore. They've got a new wave of responsibilities, especially with the globe pretty much on fire, literally and figuratively. Verdafero, a name not new to function and...

Continue Reading
India's First Upright Proton Therapy System Unveiled

Updated Category News Views 3

A Leap Forward in Cancer Care: Proton Therapy Revolution Dang, just when you think you've heard it all in cancer treatment, Fortis Healthcare drops a bombshell: India’s first upright proton therapy system. Boom! This isn't your run-of-the-mill radiation treatment we're talking about here. This is the futuristic flair of the MEVION S250-FIT™, featuring upright...

Continue Reading
Tiger Group to Auction Huge Window Manufacturing Plant

Updated Category News Views 1

Glass & Vinyl Ambitions: A New Chapter Who would have guessed? The seasoned window maker Showcase Window and Door Company is putting its prime manufacturing facility up for grabs. The online auction, orchestrated by Tiger Group, kicks off September 10, and it's sure to stir up some excitement in the industry. With picking up operations now within reach, it feels like...

Continue Reading
EQT Wraps Up Share Buyback with 4.3M Shares Repurchased

Updated Category News Views 2

EQT's Bold Buyback: Crunching the Numbers Alright, let's peel back the curtain on EQT's latest maneuver—finishing up their share buyback program, all neat and tidy for 2026. They nailed down 707,203 of their own shares just in the first week of September, part of a grand total of 4,368,899 snatched up in the entire effort. That's a whopping SEK 1.448 billion invested in...

Continue Reading
1M+ California Homes Face Extreme Wildfire Risk Revealed

Updated Category News Views 2

Wildfire Risk in California: A Growing Alarm If there's one thing that's become a bitter truth over the years, it's that California and wildfires are inseparably linked, like mayo on a greasy diner BLT—except way worse for the gut. The latest round of data from Guidewire HazardHub is practically sounding the alarm bells louder than ever. Over a million homes in...

Continue Reading
Celebree Elevates Early Ed with New Certification Push

Updated Category News Views 2

A New Standard in Early Childhood Education In the cutthroat world of childcare and early education, just meeting the state standards ain't cutting it anymore. Celebree School, known for its infant, toddler, and preschool programs, is shaking things up with its 'Celebree Certified' initiative, setting a brand-new benchmark for teacher readiness that's far beyond the usual...

Continue Reading
Dentsply Sirona Faces Insider Troubles: An Investor Call

Updated Category News Views 6

Are Dentsply Sirona Insiders on Thin Ice? The stock market's a tumultuous sea, and right now, it seems like some of those at the helm of Dentsply Sirona Inc. might be rocking the boat a bit too much. Let me tell you, navigating these corporate storms isn't for the faint-hearted. The latest noise coming from Halper Sadeh LLC suggests that some directors and officers over...

Continue Reading
Regeneron Faces Class Action Over Tumultuous Trial Results

Updated Category News Views 4

Regeneron's Meltdown: A Bitter Pill for Investors Let’s dive headlong into the mess Regeneron Pharmaceuticals (NASDAQ:REGN) finds itself in—a classic nightmare scenario for investors. News broke like an old valve bursting, and suddenly, the market's love for Regeneron ran ice-cold. Who's to blame this time? Well, you might want to point a finger at the failed Phase 3...

Continue Reading
West Texas Weather Shapes Home Design Decisions

Updated Category News Views 2

West Texas Weather: A Tough Customer for Home Builders You'd think building a house is a straightforward gig, but slap it down in West Texas, and we're talking a whole different ballgame. With its brutal heat, howling winds, and wild temperature swings, Odessa isn't just painting by numbers. It's where Mother Nature is your uninvited consultant on every single...

Continue Reading

Top 5 Most Recently Viewed Articles

Mowery & Schoenfeld Wealth Awarded Top Advisory Firm by Newsweek

Updated Category News Views 101

Mowery & Schoenfeld Wealth Celebrated as One of America’s Elite Financial Advisory Firms Mowery & Schoenfeld Wealth is thrilled to share the remarkable news of being listed among America’s Top Financial Advisory Firms for 2025 by Newsweek. This honor reflects the firm’s continuous pursuit of excellence in providing personalized financial guidance, groundbreaking...

Continue Reading
Luminar Technologies Reaches New Heights Amid Market Shifts

Updated Category News Views 221

Luminar Technologies Achieves 52-Week High In a market characterized by fluctuations and uncertainty, Luminar Technologies Inc. (NASDAQ: LAZR) has recently announced a significant achievement, touching a 52-week high of $11.39. This milestone is particularly noteworthy for a company that specializes in cutting-edge lidar sensors crucial for the operation of autonomous...

Continue Reading
AKWEL Reports Declining Revenue Over Nine-Month Period

Updated Category News Views 35

AKWEL's Revenue Decline Overview AKWEL, a distinguished manufacturer in the automotive and heavy-vehicle sectors, has recently reported its financial performance for the first nine months of the fiscal year, revealing a notable 5.2% decrease in consolidated revenue compared to the previous period. By the end of September, their revenue totaled €757.7 million, as the...

Continue Reading
Truist Securities Boosts O'Reilly Automotive Target to $1,313

Updated Category News Views 214

Truist Raises Price Target for O'Reilly Automotive Recently, Truist Securities made a notable update on O'Reilly Automotive (NASDAQ: ORLY), revising its price target from $1,290 to an impressive $1,313. This decision, backed by a Buy rating, comes on the heels of the company's robust performance in the third quarter, showing resilience despite the broader challenges faced...

Continue Reading
CGA Expands Team with Cybersecurity Experts for Impactful Insights

Updated Category News Views 304

CGA Expands Team with Cybersecurity Experts In a world where uncertainties loom large, organizations, both public and private, are in constant search of trusted partnerships that can provide clarity on government cyber policy and operations. Cambridge Global Advisors (CGA), a respected service-disabled veteran-owned small business specializing in homeland and national...

Continue Reading